--- title: "16:30 ETSenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/285612834.md" description: "SenesTech, Inc. (NASDAQ: SNES) will report its first quarter 2026 financial results on May 12, 2026, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET to discuss the results. The company focuses on fertility control for managing animal pest populations and offers EPA-compliant Rodent Birth Control™ products. Interested parties can access the call via a live webcast, with a replay available for 90 days. Forward-looking statements are included, subject to risks and uncertainties." datetime: "2026-05-07T20:30:39.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285612834.md) - [en](https://longbridge.com/en/news/285612834.md) - [zh-HK](https://longbridge.com/zh-HK/news/285612834.md) --- # 16:30 ETSenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 **_Financial results to be released after market close;_** **_Conference call to be conducted at 5:00 p.m. Eastern time_** , /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, will report financial results for its first quarter 2026, ended March 31, 2026, after the market close on Tuesday, May 12, 2026. The Company has scheduled a conference call that same day, Tuesday, May 12, 2026, at 5:00 pm ET, to review the results. **First Quarter 2026 Conference Call Details** **Date and Time:** Tuesday, March 12, 2026, at 5:00 p.m. Eastern time **Live Webcast Information**: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at https://app.webinar.net/m976bqQblKE or http://senestech.investorroom.com/. **Replay**: A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for at least 90 days. **About SenesTech **SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective and sustainable. For more information, visit https://senestech.com. **Safe Harbor Statement** _This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby._ _Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases._ _You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements._ _Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations;_ _and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025._ _All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date._ _Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise._ CONTACT: Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, \[email protected\] Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143 SOURCE SenesTech, Inc. ### Related Stocks - [SNES.US](https://longbridge.com/en/quote/SNES.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) ## Related News & Research - [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md) - [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md) - [ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership](https://longbridge.com/en/news/286787574.md) - [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md) - [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)